Today: 2 July 2026
Shell Plc stock price inches up in early London trade as buyback rolls on and oil stays in focus
17 February 2026
1 min read

Shell Plc stock price inches up in early London trade as buyback rolls on and oil stays in focus

London, Feb 17, 2026, 08:17 GMT — Regular session.

Shell (SHEL.L) climbed 0.5% to 2,879 pence early Tuesday in London, following a previous close of 2,865.5 pence, delayed exchange data showed.

Traders are once again eyeing the stock as scrutiny on buybacks intensifies across the sector, with crude prices having slipped from last year’s levels. Earlier this month, Shell kicked off a $3.5 billion repurchase and said it will cancel every share bought back. The company aims to wrap up the programme ahead of its first-quarter results, depending on market conditions.

Oil prices slipped, with Brent losing 0.86% to $68.06 a barrel by 0738 GMT. Investors are watching supply risks after Iranian naval drills took place near the Strait of Hormuz, just hours before U.S.-Iran talks are scheduled. “Market sentiment is closely tied to the tone and progress of these negotiations,” said Sugandha Sachdeva, founder of SS WealthStreet. Reuters

Shell disclosed late Monday it repurchased 1,380,295 shares for cancellation on Feb. 16, executing the buys on both London and Amsterdam exchanges. In London, the volume-weighted average landed at roughly 28.78 pounds per share; in Amsterdam, the figure came to about 33.19 euros.

Shell has stuck to a straightforward message after earnings: prioritizing returns, even as profits dip. The company posted $3.3 billion in net income for the fourth quarter, missing the $3.5 billion figure expected by analysts in its own survey. Still, Shell kept its $3.5 billion share buyback in place and bumped the dividend up 4% to $0.372 per share. Finance chief Sinead Gorman described the payout range as “sacrosanct.” Reuters

Stocks across the board leaned steady to slightly higher. As of 0805 GMT, the FTSE 100 had gained roughly 0.3%. European indexes, though, showed a mixed picture with investors weighing earnings, UK labor figures, and those ongoing U.S.-Iran nuclear discussions moving crude.

The bearish scenario for energy stocks hasn’t disappeared. Citi notes that while geopolitical flare-ups could keep oil prices elevated for now, Brent could slide to $60–$62 a barrel if Iran and Russia-Ukraine agreements materialize by summer. The bank also pointed out that OPEC+ may boost supply from April if crude holds in the mid-$60s to $70 zone.

Shell’s dividend schedule is the next milestone for investors. Shares go ex-dividend on Feb. 19, so anyone picking up stock after that won’t get the next 37.20 cent fourth-interim dividend, which lands on March 30.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • S&P 500, Nasdaq Drop as Money Moves Out of Tech; Dow Unchanged
    July 1, 2026, 6:56 PM EDT. S&P 500 lost 0.2% and the Nasdaq 100 fell 1.5% as traders pulled back from tech and chip names. Dow Jones stayed flat. The VanEck Semiconductor ETF dropped 5.5% after a strong run last quarter, suggesting some profit-taking. Oil gave back its post-Iran war gains. Treasury yields slipped, giving some relief to the economy. Fed Chair Kevin Warsh played down AI-driven job loss worries, saying AI could help growth and jobs. Flows continue shifting toward blue-chip industrials. Retail investor sentiment is mixed in major ETFs.
Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe
Previous Story

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod
Next Story

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod

Go toTop